Tin tức & Cập nhật
Xem bài viết Tâm thần
Xem
Chỉ hiển thị Multimedia

Esketamine combined with SSRI or SNRI leads to different outcomes in treatment-resistant depression
30 Apr 2025
bởiKanas Chan
Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) reduces rates of mortality, hospitalizations, and depressive relapses, while esketamine combined with a selective serotonin reuptake inhibitor (SSRI) decreases the incidence of suicidal attempts, a real-world comparative effectiveness study on treatment-resistant depression (TRD) has shown.
30 Apr 2025







